Yongin-si, South Korea

Hae Tak Jin


Average Co-Inventor Count = 15.9

ph-index = 5

Forward Citations = 63(Granted Patents)


Location History:

  • Yongin-si, KR (2004 - 2005)
  • Yongin, KR (2004 - 2006)

Company Filing History:


Years Active: 2004-2006

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Hae Tak Jin

Introduction

Hae Tak Jin is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work focuses on developing novel compounds and methods that enhance therapeutic efficacy.

Latest Patents

Among his latest patents are two notable inventions. The first is a 1,2,4-Triazole derivative, which includes a method for preparing the same and a pharmaceutical composition containing this derivative as an active ingredient. This invention aims to provide a non-toxic salt of the derivative, enhancing its usability in medical applications. The second patent involves a novel crystalline organic acid salt of amlodipine, which boasts improved physiochemical properties. This invention also includes a preparation method and a pharmaceutical composition that incorporates this new salt.

Career Highlights

Hae Tak Jin is associated with CJ Corporation, a leading company in the pharmaceutical industry. His work at CJ Corporation has allowed him to focus on innovative drug development, contributing to advancements in medical treatments.

Collaborations

He has collaborated with notable colleagues, including Sung Hak Jung and Kyu Jeong Yeon, to further enhance the scope and impact of his research.

Conclusion

Hae Tak Jin's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His patents reflect a dedication to developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…